While no change in ADAM17 immunoreactivity was detected in LV tissue of the different CHF subgroups, lower levels were observed in the RV chamber of decompensated CHF animals (0.75 ± 0.07; P < .05) (Figure 5D,F). This evidence concerns the gene ADAM17 and congestive heart failure.